Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 11/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CTSS | P25774 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8027247 | 1.00 | CA1 (0.44) | CA1CA2CA7CTSKATM | |
| SCHEMBL12954731 | 0.90 | CA1 (0.41) | CA1CA2CA7CTSKATM | |
| SCHEMBL3126966 | 0.89 | ITGB3 (0.41) | CA1CA2CA7CTSKATM | |
| SCHEMBL22433832 | 0.88 | CA1 (0.45) | CA1CA2CA7CTSKATM | |
| SCHEMBL10012149 | 0.86 | CTSK (0.44) | CA1CA2CA7CTSKATM | |
| SCHEMBL12666358 | 0.86 | CA1 (0.46) | CA1CA2CA7CTSKATM | |
| SCHEMBL7642781 | 0.86 | CA1 (0.46) | CA1CA2CA7CTSKATM | |
| SCHEMBL7642786 | 0.86 | CA1 (0.46) | CA1CA2CA7CTSKATM | |
| SCHEMBL15968788 | 0.86 | CA1 (0.46) | CA1CA2CA7CTSKATM | |
| SCHEMBL2617386 | 0.86 | CA1 (0.46) | CA1CA2CA7CTSKATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116802184-A | Pyrazolothiazole carboxamides and their use as PDGFR inhibitors | 埃科特莱茵药品有限公司 | 2023-09-22 | — | — | CN | disclosed |